Clinical Report: Choriocarcinoma of Non-Gestational Origin in a Male

Background

Non-gestational choriocarcinoma is a rare and aggressive malignancy in males, often diagnosed at advanced stages due to atypical presentations. It accounts for less than 0.1% of all testicular tumors and can manifest in various anatomical sites, complicating diagnosis.

Data Highlights

No numerical data is available in the source material.

Key Findings

• NGCC can present as cervical lymphadenopathy, which is uncommon in males.
• The patient had markedly elevated serum β-hCG levels at 4278 IU/L, with normal AFP levels.
• Histopathological examination revealed highly atypical tumor cells with extensive necrosis.
• Immunohistochemical analysis showed positivity for pan-cytokeratin and β-hCG.
• The Ki-67 proliferation index was approximately 90%, indicating high tumor aggressiveness.

Clinical Implications

Healthcare professionals should consider NGCC in the differential diagnosis for male patients presenting with unexplained cervical lymphadenopathy and elevated β-hCG levels.

Conclusion

This case underscores the importance of recognizing NGCC in atypical presentations to facilitate timely diagnosis and management.

Related Resources & Content

1. Frontiers in Oncology, 2026 -- Non-gestational choriocarcinoma presenting as cervical lymphadenopathy in a male patient: a case report
2. Frontiers in Oncology — Case Report: Primary hepatic carcinosarcoma with ectopic β-hCG secretion and a paraneoplastic leukemoid reaction mimicking gynecologic and hematologic disease
3. Frontiers in Surgery — INI-1 Loss with Brachyury Positivity Unmasking a Cervical Poorly Differentiated Chordoma Initially Diagnosed as Epithelioid Sarcoma: A Case Report
4. Frontiers in Oncology — Mesonephric-like adenocarcinoma as an unexpected histological result after fertility saving procedure for presumed adenomyosis: a case report
5. Frontiers in Surgery — Giant Adenoid Cystic Carcinoma in the Subglottic Region: A Case Study
6. Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up†
7. Frontiers | Non-gestational choriocarcinoma presenting as cervical lymphadenopathy in a male patient: a case report
8. https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelines-on-Testicular-Cancer-2026.pdf
9. An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin - PMC
10. Fluorescence In Situ Hybridization (FISH) Detection of Chromosomal 12p Anomalies in Testicular Germ Cell Tumors - PubMed
11. Testicular Cancer (male germ cell tumors)
12. Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study. | Journal of Clinical Oncology
13. Personalised chemotherapy based on tumour marker decline in poor-prognosis germ-cell tumours: results of the GETUG 13 phase III trial - PMC